FDA approves new version of diabetes drug Mounjaro for weight loss ...Middle East

A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday. The U.S. Food and Drug Administration approved Eli Lilly’s drug, named Zepbound. The drug, also known as tirzepatide, helped dieters lose as much as 40 to 60 pounds in testing. Zepbound is the latest diabetes drug approved for chronic weight management, joining Novo Nordisk’s Wegovy, a high-dose version of its diabetes treatment Ozempic. Both are weekly injections. The FDA approved Lilly’s drug for people who are considered obese, with a body mass index of 30 or higher, or those who are overweight with a related health condition, like high blood pressure, high chol

Hence then, the article about fda approves new version of diabetes drug mounjaro for weight loss was published today ( Thursday 09/11/2023 - 03:05 AM ) and is available on Sentinel-Tribune ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA approves new version of diabetes drug Mounjaro for weight loss )

Also on site :

• Golfer Masashi ‘Jumbo’ Ozaki dies at 78
• Nona Biosciences Expands Integrated Discovery-to-Clinical Capabilities Through Strategic Platform Growth
• Sanofi to Acquire Dynavax, Adding a Marketed Adult Hepatitis B Vaccine and Phase 1/2 Shingles Candidate to the Pipeline